Luyan Pharma Co.,Ltd.
SZSE:002788.SZ
8.78 (CNY) • At close October 26, 2023
Overview | Financials
Numbers are in millions (except for per share data and ratios) CNY.
| 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating Activities: | |||||||||||||
| Net Income
| 364.494 | 350.974 | 304.611 | 267.809 | 257.51 | 184.581 | 145.006 | 116.773 | 115.206 | 110.972 | 109.116 | 91.377 | 63.625 |
| Depreciation & Amortization
| 120.614 | 112.778 | 112.771 | 47.585 | 42.109 | 34.824 | 25.526 | 21.574 | 20.335 | 17.487 | 10.793 | 7.722 | 0 |
| Deferred Income Tax
| -11.923 | -11.524 | -7.912 | -7.025 | -4.961 | 6.421 | -8.256 | -7.334 | -3.328 | 0 | 0 | 0 | 0 |
| Stock Based Compensation
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Change In Working Capital
| 562 | -520.811 | -1,027.376 | -456.649 | -1,122.994 | -234.129 | -707.227 | -346.112 | -221.756 | -30.937 | -260.52 | -174.727 | 0 |
| Accounts Receivables
| 473.895 | -1,119.86 | -998.542 | -377.973 | -946.705 | -175.296 | -408.239 | 45.419 | -206.072 | -137.096 | -272.026 | -479.347 | 0 |
| Inventory
| -29.274 | -276.227 | -253.578 | -279.533 | -463.679 | -145.492 | -174.421 | -184.245 | -46.693 | -70.874 | -38.373 | -201.818 | 0 |
| Accounts Payables
| 129.303 | 886.799 | 232.656 | 190.048 | 292.351 | 80.238 | -116.312 | -199.952 | 34.336 | 0 | 0 | 0 | 0 |
| Other Working Capital
| -11.923 | -11.524 | -7.912 | 10.81 | -4.961 | -88.637 | -532.806 | -161.867 | -175.063 | 39.937 | -222.146 | 27.091 | 0 |
| Other Non Cash Items
| 262.009 | 289.246 | 237.972 | 218.478 | 194.236 | 141.494 | 89.531 | 79.738 | 86.435 | 80.367 | 64.145 | 42.684 | -63.625 |
| Operating Cash Flow
| 1,309.117 | 232.186 | -372.021 | 77.223 | -629.14 | 126.77 | -447.164 | -128.028 | 0.219 | 177.889 | -76.465 | -32.944 | 28.006 |
| Investing Activities: | |||||||||||||
| Investments In Property Plant And Equipment
| -529.208 | -327.583 | -243.491 | -170.625 | -198.9 | -133.884 | -84.234 | -110.159 | -42.282 | -85.137 | -137.495 | -85.517 | -34.053 |
| Acquisitions Net
| 7.462 | 3.795 | -3.744 | -9.537 | -28.946 | -277.064 | -203.504 | 10.49 | -0.299 | 15.406 | -33.001 | -6.056 | -9.03 |
| Purchases Of Investments
| -12.947 | -2.03 | -32.53 | -2,668.03 | -2,648 | -1,226.175 | -0.5 | 0 | 0 | -1.69 | 0 | 0 | 0.115 |
| Sales Maturities Of Investments
| 0.022 | 0.105 | 2.455 | 2,669.3 | 2,649.397 | 1,245.44 | 86.95 | 0 | 0 | 85.317 | 0 | 0 | 0.279 |
| Other Investing Activites
| 0.426 | -3.45 | 3.954 | 0.288 | 0.493 | -0.778 | -84.234 | 0.478 | 0.128 | -85.137 | 0.117 | 0.078 | 0.3 |
| Investing Cash Flow
| -534.244 | -329.163 | -273.355 | -178.604 | -225.956 | -392.46 | -285.522 | -99.192 | -42.453 | -71.241 | -170.379 | -91.494 | -42.389 |
| Financing Activities: | |||||||||||||
| Debt Repayment
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Common Stock Issued
| 0 | 0 | 11.4 | 1.6 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Common Stock Repurchased
| 0 | 0 | -11.4 | -1.6 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Dividends Paid
| -116.555 | -116.555 | -98.895 | -49.025 | -38.451 | -177.023 | -98.303 | -91.538 | -94.697 | -93.853 | -58.05 | -37.488 | -40.081 |
| Other Financing Activities
| -114.54 | 8,613.701 | 6,480.087 | 5,625.217 | 4,874.016 | 3,519.636 | 2,591.327 | 3,319.786 | 3,076.208 | 2,870.133 | 2,699.232 | 1,584.935 | 643.887 |
| Financing Cash Flow
| -708.985 | 184.461 | 475.684 | 295.934 | 747.598 | 205.462 | 770.753 | 180.253 | -67.636 | 116.881 | 306.049 | 241.57 | 51.995 |
| Other Information: | |||||||||||||
| Effect Of Forex Changes On Cash
| 0.821 | 2.387 | -0.705 | -1.351 | 0.377 | 0.593 | -0.565 | 0.541 | 0.416 | 0.23 | -0.175 | -0.025 | -0.001 |
| Net Change In Cash
| 66.709 | 89.871 | -170.398 | 193.201 | -107.12 | -59.635 | 37.502 | -46.426 | -109.453 | 223.759 | 59.03 | 117.107 | 37.611 |
| Cash At End Of Period
| 461.508 | 394.8 | 304.928 | 473.777 | 280.575 | 387.696 | 447.331 | 409.829 | 456.254 | 565.707 | 341.948 | 282.918 | 165.688 |